phytanic acid has been researched along with Adrenoleukodystrophy in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 12 (48.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scott, AI | 1 |
| De Biase, I; Pasquali, M | 1 |
| Horibe, R; Kondo, N; Shimozawa, N; Suzuki, Y; Takemoto, Y; Wanders, RJ | 1 |
| Poulos, A; Sharp, P | 1 |
| Applegarth, D; Vallance, H | 1 |
| Molzer, B; Schmitt, K; Stöckler, S; Tulzer, G; Tulzer, W | 1 |
| Eyssen, HJ; Huang, S; Mannaerts, GP; Van Veldhoven, PP | 1 |
| Bernheimer, H; Gullotta, F; Harzer, K; Molzer, B; Poulos, A | 1 |
| Molzer, B | 1 |
| McGuinness, MC; Moser, AB; Poll-The, BT; Watkins, PA | 1 |
| Dhaunsi, GS; Lazo, O; Ozand, P; Pahan, K; Singh, I | 1 |
| Cocquyt, G; Dacremont, G; Vincent, G | 1 |
| Braiterman, LT; Moser, AB; Smith, KD; Watkins, PA | 1 |
| Hakkola, E; Hiltunen, K; Kilponen, J; Palosaari, P | 1 |
| Demaugre, F; Poll-The, BT; Saudubray, JM; Skjeldal, OH; Stokke, O | 1 |
| Kamoshita, S | 1 |
| Danks, DM; Fellenberg, AJ; Poulos, A; Sharp, P | 1 |
| Norseth, J; Petit, H; Refsum, S; Skjeldal, OH; Stokke, O | 1 |
| Kolodny, EH | 1 |
| Baldwin, V; Charrow, J; Chen, WW; Friedman, JM; Hoefler, G; Hoefler, S; McGillivary, B; Moser, A; Rutledge, L; Watkins, PA | 1 |
| Fellenberg, AJ; Johnson, DW; Poulos, A; Sharp, P | 1 |
| Hall, NA; Hjelm, NM; Lynes, GW | 1 |
| Demaugre, F; Poll-The, BT; Poulos, A; Saudubray, JM; Skjeldal, OH; Stokke, O | 1 |
| Bernheimer, H; Kainz-Korschinsky, M; Molzer, B; Sundt-Heller, R | 1 |
| Björkhem, I; Ek, J; Kase, BF; Pedersen, JI; Reith, A | 1 |
3 review(s) available for phytanic acid and Adrenoleukodystrophy
| Article | Year |
|---|---|
Diagnosis of peroxisomal disorders with neurological involvement.
Topics: Adrenoleukodystrophy; Fatty Acids; Humans; Infant, Newborn; Metabolism, Inborn Errors; Microbodies; Nervous System Diseases; Phytanic Acid; Zellweger Syndrome | 1993 |
[Peroxisomal diseases--pediatric and neurologic differential diagnosis].
Topics: Adrenoleukodystrophy; Child, Preschool; Diagnosis, Differential; Fatty Acids; Genetic Counseling; Humans; Infant; Intellectual Disability; Metabolism, Inborn Errors; Microbodies; Phytanic Acid | 1991 |
[Peroxisomal disorders; newer concept and recent studies].
Topics: Adrenoleukodystrophy; Bile Acids and Salts; Diffuse Cerebral Sclerosis of Schilder; Humans; Microbodies; Phytanic Acid; Pipecolic Acids; Plasmalogens; Zellweger Syndrome | 1990 |
22 other study(ies) available for phytanic acid and Adrenoleukodystrophy
| Article | Year |
|---|---|
Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
Topics: Adrenoleukodystrophy; Fatty Acids; Gas Chromatography-Mass Spectrometry; Humans; Phytanic Acid; Solvents | 2022 |
Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Adrenoleukodystrophy; ATP-Binding Cassette Transporters; Bile Acids and Salts; Chromatography, Liquid; Coenzyme A; Deanol; Esters; Fatty Acids; Humans; Iodides; Peroxisomal Disorders; Phytanic Acid; Tandem Mass Spectrometry | 2022 |
Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Topics: Adolescent; Adrenoleukodystrophy; Case-Control Studies; Docosahexaenoic Acids; Fatty Acids; Gas Chromatography-Mass Spectrometry; Humans; Infant; Peroxisomal Disorders; Phytanic Acid; Plasmalogens; Refsum Disease; Zellweger Syndrome | 2003 |
Plasma and skin fibroblast C26 fatty acids in infantile Refsum's disease.
Topics: Adrenoleukodystrophy; Child, Preschool; Fatty Acids; Female; Fibroblasts; Humans; Infant; Male; Phytanic Acid; Refsum Disease; Skin | 1984 |
An improved method for quantification of very long chain fatty acids in plasma.
Topics: Adrenoleukodystrophy; Adult; Chondrodysplasia Punctata; Fatty Acids; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Microbodies; Molecular Weight; Phytanic Acid; Reference Standards; Reference Values; Refsum Disease; Reproducibility of Results; Zellweger Syndrome | 1994 |
[Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
Topics: Adrenoleukodystrophy; Catalase; Fatty Acids; Humans; Infant; Male; Microbodies; Phytanic Acid; Plasmalogens; Refsum Disease; Zellweger Syndrome | 1993 |
The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Topics: Adrenoleukodystrophy; Cell Line; Fatty Acids; Fibroblasts; Humans; Kinetics; Microbodies; Oxidation-Reduction; Palmitates; Phytanic Acid; Refsum Disease; X Chromosome; Zellweger Syndrome | 1993 |
Unusual orthochromatic leukodystrophy with epitheloid cells (Norman-Gullotta): increase of very long chain fatty acids in brain discloses a peroxisomal disorder.
Topics: Adrenoleukodystrophy; Aged; Aged, 80 and over; Brain; Brain Chemistry; Cholesterol Esters; Fatty Acids; Humans; Microbodies; Phytanic Acid | 1993 |
Complementation analysis of patients with intact peroxisomes and impaired peroxisomal beta-oxidation.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Adrenoleukodystrophy; Cell Line; Enoyl-CoA Hydratase; Fatty Acids; Humans; Immunoblotting; Microbodies; Oxidation-Reduction; Phytanic Acid; Zellweger Syndrome | 1993 |
Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz.
Topics: Adrenoleukodystrophy; Animals; Cell Fractionation; Cells, Cultured; Centrifugation, Density Gradient; Chlorides; Chondrodysplasia Punctata; Epoxy Compounds; Fatty Acids; Ferric Compounds; Fibroblasts; Humans; Hypoglycemic Agents; Iohexol; Kinetics; Liver; Microbodies; Mitochondria; Organelles; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Phytanic Acid; Rats; Rats, Sprague-Dawley; Skin; Subcellular Fractions; Zellweger Syndrome | 1993 |
Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography.
Topics: Adrenoleukodystrophy; Cells, Cultured; Chromatography, Gas; Esters; Fatty Acids; Fibroblasts; Humans; Indicators and Reagents; Phytanic Acid; Solutions; Solvents | 1995 |
Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
Topics: Adrenoleukodystrophy; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Cell Line; Cell Line, Transformed; Fatty Acids, Nonesterified; Fibroblasts; Humans; Membrane Proteins; Microbodies; Oxidation-Reduction; Phytanic Acid; Reference Values; Simian virus 40; Skin | 1999 |
Complementation analysis of peroxisomal disorders and classical Refsum.
Topics: Adrenoleukodystrophy; Cells, Cultured; Diffuse Cerebral Sclerosis of Schilder; Fibroblasts; Genetic Complementation Test; Humans; Infant; Microbodies; Phytanic Acid; Refsum Disease; Zellweger Syndrome | 1990 |
Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase.
Topics: Adrenoleukodystrophy; Brain Diseases; Cells, Cultured; Child, Preschool; Chromatography, Gas; Diffuse Cerebral Sclerosis of Schilder; Eicosanoic Acids; Fatty Acids; Female; Fibroblasts; Genetic Linkage; Humans; Infant; Infant, Newborn; Kidney Diseases; Liver Diseases; Male; Mixed Function Oxygenases; Oxidoreductases; Phytanic Acid; Pipecolic Acids; Refsum Disease; Skin; Syndrome; X Chromosome | 1985 |
Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
Topics: Adrenoleukodystrophy; Adult; Aged; Eicosanoic Acids; Female; Fibroblasts; Humans; Male; Middle Aged; Mixed Function Oxygenases; Oxidoreductases; Phytanic Acid; Refsum Disease; Skin; Syndrome | 1987 |
The adrenoleukodystrophy-adrenomyeloneuropathy complex: is it treatable?
Topics: Adrenoleukodystrophy; Dietary Fats; Diffuse Cerebral Sclerosis of Schilder; Fatty Acids; Heterozygote; Humans; Oleic Acid; Oleic Acids; Phytanic Acid; Refsum Disease; Syndrome | 1987 |
Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
Topics: Acetyl-CoA C-Acyltransferase; Adrenoleukodystrophy; Chondrodysplasia Punctata; Female; Fibroblasts; Humans; Infant; Infant, Newborn; Liver; Male; Microbodies; Phytanic Acid; Plasmalogens; Refsum Disease | 1988 |
Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
Topics: Adrenoleukodystrophy; Chondrodysplasia Punctata; Fatty Acids; Humans; Lipidoses; Microbodies; Phytanic Acid; Refsum Disease | 1988 |
Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.
Topics: Adolescent; Adrenoleukodystrophy; Adult; Aging; Child; Child, Preschool; Chromatography, High Pressure Liquid; Fatty Acids; Female; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Lipid Metabolism, Inborn Errors; Male; Microbodies; Middle Aged; Phytanic Acid; Reference Values; Refsum Disease; Syndrome | 1988 |
Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
Topics: Adrenoleukodystrophy; Cells, Cultured; Chondrodysplasia Punctata; Eicosanoic Acids; Fibroblasts; Genetic Complementation Test; Humans; Microbodies; Oxidation-Reduction; Phytanic Acid; Refsum Disease; Zellweger Syndrome | 1989 |
Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Topics: Adrenal Glands; Adrenoleukodystrophy; Brain; Cholesterol Esters; Eicosanoic Acids; Fatty Acids; Humans; Kidney; Lipid Metabolism, Inborn Errors; Microbodies; Phytanic Acid; Refsum Disease; Zellweger Syndrome | 1989 |
Peroxisomal dysfunction in a boy with neurologic symptoms and amaurosis (Leber disease): clinical and biochemical findings similar to those observed in Zellweger syndrome.
Topics: Adrenoleukodystrophy; Biopsy; Blindness; Brain Diseases; Cells, Cultured; Diagnosis, Differential; Female; Fibroblasts; Hearing Loss, Sensorineural; Hepatomegaly; Humans; Infant; Intellectual Disability; Kidney Diseases; Liver; Liver Diseases; Male; Microbodies; Oxidation-Reduction; Phytanic Acid; Plasmalogens; Syndrome | 1986 |